“FDA Approved Empagliflozin for Adults with Chronic Kidney Disease at Risk of Progression”

Document Type

News Article

Publication Date

8-1-2023

Keywords

washington; spokane; prmc

Clinical Institute

Kidney & Diabetes

Department

Endocrinology

Department

Nephrology

Comments

Pharmacy Times

This document is currently not available here.


Share

COinS